Scientific Reports (Feb 2018)

STAT3 regulates cytotoxicity of human CD57+ CD4+ T cells in blood and lymphoid follicles

  • Jalila Alshekaili,
  • Rochna Chand,
  • Cindy Eunhee Lee,
  • Susan Corley,
  • Kristy Kwong,
  • Ilenia Papa,
  • David A. Fulcher,
  • Katrina L. Randall,
  • Jennifer W. Leiding,
  • Cindy S. Ma,
  • Marc R. Wilkins,
  • Gulbu Uzel,
  • Chris C. Goodnow,
  • Carola G. Vinuesa,
  • Stuart G. Tangye,
  • Matthew C. Cook

DOI
https://doi.org/10.1038/s41598-018-21389-8
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 11

Abstract

Read online

Abstract A subset of human follicular helper T cells (TFH) cells expresses CD57 for which no distinct function has been identified. We show that CD57+ TFH cells are universally PD-1hi, but compared to their CD57− PD-1hi counterparts, express little IL-21 or IL-10 among others. Instead, CD57 expression on TFH cells marks cytotoxicity transcriptional signatures that translate into only a weak cytotoxic phenotype. Similarly, circulating PD-1+ CD57+ CD4+ T cells make less cytokine than their CD57− PD-1+ counterparts, but have a prominent cytotoxic phenotype. By analysis of responses to STAT3-dependent cytokines and cells from patients with gain- or loss-of-function STAT3 mutations, we show that CD4+ T cell cytotoxicity is STAT3-dependent. TFH formation also requires STAT3, but paradoxically, once formed, PD-1hi cells become unresponsive to STAT3. These findings suggest that changes in blood and germinal center cytotoxicity might be affected by changes in STAT3 signaling, or modulation of PD-1 by therapy.